Report cover image

Growth Opportunities in Radiopharmaceuticals

Publisher Frost & Sullivan
Published Oct 07, 2025
SKU # MC20468959

Description

The report covers the clinical trial assessment for radiodiagnostics, including PET, SPECT, and radiopharmaceuticals, comprising Alpha therapy, Beta therapy, Auger Therapy, and Theranostics. The report covers the key players in each space and their contributions to the radiopharmaceuticals landscape.

The report sheds light on technology innovations to make better radiopharmaceuticals. The radiopharmaceuticals industry is at the cusp of a high-confidence phase, with investors, CDMOs, and big pharmaceutical firms engaging in fundraising rounds, licensing agreements, acquisitions, and strategic collaborations. This research provides insights into partnerships, collaborations, acquisitions/mergers, and private funding activities that contribute to the growth of radiopharmaceuticals.

Key questions this report answers:
What are the key drivers and challenges for the development of radiopharmaceuticals?
What is the pace of clinical development in each segment?
Who are the leading industry participants developing innovative radiopharmaceuticals?
What does the funding and partnership landscape look like for radiopharmaceuticals?
What are the growth opportunities in radiopharmaceuticals?

Table of Contents

    • Why Is It Increasingly Difficult to Grow?
    • The Strategic Imperative 8
    • The Impact of the Top 3 Strategic Imperatives on the Industry
    • Growth Opportunities Fuel the Growth Pipeline Engine ne
    • Research Methodology
    • Scope of Analysis
    • Segmentation
    • Growth Drivers
    • Growth Restraints
    • Introduction: Radiopharmaceuticals Gaining Traction
    • PET Analysis for Oncology Growth Opportunities in2024-20XX
    • PET Imaging Radiopharmaceuticals Growth Opportunities in2024-20XX
    • SPECT Analysis for Radio Diagnostics
    • Key Innovators—Radiodiagnostics Growth Opportunities in2024-20XX
    • Comparative Analysis of Radiotherapies
    • Overview of the Radiotherapeutics Pipeline
    • Key Trends in Radiopharmaceuticals
    • Radiopharmaceuticals—Innovator Spotlight
    • Technological Innovation in Radiopharmaceuticals
    • Targeting Strategies and Radiochemistry Advances—Innovations
    • Novel Radioisotopes—Innovations
    • Drug Delivery—Innovations
    • Private Funding for Radiotherapeutics
    • Overview of the Acquisition Landscape for Radiopharmaceuticals
    • Partnership Landscape in Radiopharmaceuticals
    • Key Insights
    • Global M&A; Partnerships Landscape
    • Radiopharma Companies on Global Map
    • Insights from Radiopharmaceuticals Experts
    • Growth Opportunity 1: Focus on Alpha Therapies
    • Growth Opportunity 2: Focus on Radiotherapeutics
    • Growth Opportunity 3: Focus on Novel Targets
    • PET Imaging Radiopharmaceuticals Growth Opportunities in2024-20XX
    • Clinical Pipeline Analysis of Key Industry Players—Radiotherapeutics
    • Technology Readiness Levels (TRL): Explanation
    • Benefits and Impacts of Growth Opportunities
    • Next Steps
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.